Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I".

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMC 2824819)

Published in PLoS One on February 19, 2010

Authors

Hai Yu1, Quan Yuan, Sheng-Xiang Ge, Hurng-Yi Wang, Ya-Li Zhang, Qing-Rui Chen, Jun Zhang, Pei-Jer Chen, Ning-Shao Xia

Author Affiliations

1: National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China.

Articles citing this

A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLoS One (2012) 1.07

Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau. PLoS One (2011) 0.97

Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa. PLoS One (2012) 0.95

Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter? World J Gastroenterol (2014) 0.91

Disparate distribution of hepatitis B virus genotypes in four sub-Saharan African countries. J Clin Virol (2013) 0.89

Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89

Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation? PLoS One (2011) 0.88

Characterization of hepatitis B virus (HBV) genotypes in patients from Rondônia, Brazil. Virol J (2010) 0.88

Overview of hepatitis B viral replication and genetic variability. J Hepatol (2016) 0.87

Molecular characterization of hepatitis B virus in liver disease patients and asymptomatic carriers of the virus in Sudan. BMC Infect Dis (2013) 0.87

The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics. Rev Med Virol (2016) 0.86

Mutation Reporter Tool: an online tool to interrogate loci of interest, with its utility demonstrated using hepatitis B virus. Virol J (2013) 0.86

Clinical significance of hepatitis B surface antigen mutants. World J Hepatol (2015) 0.82

HBV endemicity in Mexico is associated with HBV genotypes H and G. World J Gastroenterol (2013) 0.82

Molecular epidemiology of hepatitis B and hepatitis delta viruses circulating in the Western Amazon region, North Brazil. BMC Infect Dis (2014) 0.82

A high variability of mixed infections and recent recombinations of hepatitis B virus in Laos. PLoS One (2012) 0.81

Fragment merger: an online tool to merge overlapping long sequence fragments. Viruses (2013) 0.81

High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011. BMC Infect Dis (2013) 0.81

RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivo. BMC Microbiol (2010) 0.80

Occult hepatitis B virus infection in chacma baboons, South Africa. Emerg Infect Dis (2013) 0.80

Phylogenetic analysis of complete genome sequences of hepatitis B virus from an Afro-Colombian community: presence of HBV F3/A1 recombinant strain. Virol J (2012) 0.80

Hepatitis B virus genotypes and genome characteristics in China. World J Gastroenterol (2015) 0.80

Full-genome sequence of a hepatitis B virus genotype f1b clone from a chronically infected chilean patient. Genome Announc (2014) 0.79

Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings? Hepat Mon (2012) 0.79

Prevalence of genotypes and subtypes of hepatitis B viruses in Bangladeshi population. Springerplus (2016) 0.78

Molecular epidemiological study of hepatitis B virus in blood donors from five Chinese blood centers. Arch Virol (2012) 0.78

The Effect of HBV Genotype C on the Development of HCC Differs Between Wild-Type Viruses and Those With BCP Double Mutations (T(1762)A(1764)). Hepat Mon (2014) 0.77

An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients. Virol J (2011) 0.77

Molecular characterisation of hepatitis B virus in the resident Chinese population in Panama City. Mem Inst Oswaldo Cruz (2013) 0.77

Detection of Hepatitis B virus subgenotype A1 in a Quilombo community from Maranhão, Brazil. Virol J (2011) 0.76

Sequence-based genotyping of hepatitis B virus in general population. Med J Islam Repub Iran (2015) 0.75

Resolving ambiguity in the phylogenetic relationship of genotypes A, B, and C of hepatitis B virus. BMC Evol Biol (2013) 0.75

Genetic Diversity of the Hepatitis B Virus Strains in Cuba: Absence of West-African Genotypes despite the Transatlantic Slave Trade. PLoS One (2015) 0.75

Bioinformatic curation and alignment of genotyped hepatitis B virus (HBV) sequence data from the GenBank public database. Springerplus (2016) 0.75

Molecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan. PLoS One (2016) 0.75

The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant. Biomed Res Int (2017) 0.75

Articles cited by this

MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform (2008) 24.69

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A (1987) 8.11

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol (2000) 5.76

Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol (1988) 5.75

Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology (1994) 4.77

Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol (2002) 4.22

Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology (2004) 4.12

A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol (1995) 3.35

Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A (2002) 2.71

Hepatitis B virus genotypes. Vaccine (2005) 2.56

Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46

Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol (2005) 2.24

A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol (2009) 2.20

An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A (2006) 1.99

New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol (2008) 1.95

Hepatitis B virus: significance of genotypes. J Viral Hepat (2005) 1.87

Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology (2006) 1.60

An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam. J Gen Virol (2000) 1.58

Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol (2008) 1.51

Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis (2008) 1.48

Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol (1987) 1.41

Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol (1992) 1.37

Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro. Lab Invest (1988) 1.15

When should "I" consider a new hepatitis B virus genotype? J Virol (2008) 1.13

Under construction: classification of hepatitis B virus genotypes and subgenotypes. Intervirology (2009) 0.96

Detection of a newly identified hepatitis B virus genotype in southeastern France. J Clin Virol (2009) 0.82

Articles by these authors

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet (2010) 7.11

Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res (2013) 6.89

Adaptive particle swarm optimization. IEEE Trans Syst Man Cybern B Cybern (2009) 6.47

Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med (2002) 6.20

Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science (2006) 5.52

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02

Hepatitis E. Lancet (2012) 4.43

Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology (2014) 3.92

Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A (2011) 3.80

Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med (2003) 3.57

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol (2010) 3.55

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst (2005) 3.48

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity (2002) 3.46

Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol (2005) 3.33

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol (2011) 3.32

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst (2008) 3.27

Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med (2012) 3.20

Light-avoidance-mediating photoreceptors tile the Drosophila larval body wall. Nature (2010) 3.13

Respiratory morbidity in late preterm births. JAMA (2010) 3.11

A global reference for fetal-weight and birthweight percentiles. Lancet (2011) 3.05

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial. Clin Infect Dis (2008) 3.01

Long-term efficacy of a hepatitis E vaccine. N Engl J Med (2015) 3.00

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology (2003) 2.97

Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey. Lancet (2013) 2.89

Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial. Ann Intern Med (2013) 2.84

The crystal structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into metabolite gating. Proc Natl Acad Sci U S A (2008) 2.82

Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem (2004) 2.79

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol (2005) 2.58

Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol (2013) 2.58

Adaptive genic evolution in the Drosophila genomes. Proc Natl Acad Sci U S A (2007) 2.56

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology (2008) 2.55

Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res (2003) 2.52

Markers for detergent-resistant lipid rafts occupy distinct and dynamic domains in native membranes. Mol Biol Cell (2004) 2.50

How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol (2007) 2.48

Protein adducts generated from products of lipid oxidation: focus on HNE and one. Drug Metab Rev (2006) 2.46

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology (2008) 2.46

Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A (2003) 2.44

Labor progression and risk of cesarean delivery in electively induced nulliparas. Obstet Gynecol (2005) 2.44

Electronic origin of high-temperature superconductivity in single-layer FeSe superconductor. Nat Commun (2012) 2.37

High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology (2012) 2.36

Phase diagram and electronic indication of high-temperature superconductivity at 65 K in single-layer FeSe films. Nat Mater (2013) 2.34

A unified framework for gesture recognition and spatiotemporal gesture segmentation. IEEE Trans Pattern Anal Mach Intell (2009) 2.34

The research implications of the selection of a gestational age estimation method. Paediatr Perinat Epidemiol (2007) 2.29

Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res (2002) 2.28

Cryptochromes define a novel circadian clock mechanism in monarch butterflies that may underlie sun compass navigation. PLoS Biol (2008) 2.28

The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat Immunol (2003) 2.26

Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol (2010) 2.20

P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology (2002) 2.18

Mapping the murine cardiac 26S proteasome complexes. Circ Res (2006) 2.17

Sperm, but not oocyte, DNA methylome is inherited by zebrafish early embryos. Cell (2013) 2.16

Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem (2004) 2.16

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology (2003) 2.15

Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma. J Hepatol (2011) 2.12

Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis (2010) 2.02

Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci (2011) 2.02

Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr (2009) 2.00

Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy. Antivir Ther (2014) 1.99

An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A (2006) 1.99

Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following Vitamin A supplementation. Invest Ophthalmol Vis Sci (2008) 1.96

Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci (2007) 1.94

Hidden dynamic allostery in a PDZ domain. Proc Natl Acad Sci U S A (2009) 1.93

Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature (2008) 1.91

Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology (2004) 1.89

Drag reduction through self-similar bending of a flexible body. Nature (2002) 1.89

Dynamic morphology of clear corneal cataract incisions. Ophthalmology (2003) 1.88

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology (2006) 1.87

Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics (2009) 1.85

RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology (2005) 1.85

Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis (2006) 1.84

Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis (2006) 1.84

Using a simplified Bishop score to predict vaginal delivery. Obstet Gynecol (2011) 1.83

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. J Hepatol (2009) 1.82

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology (2008) 1.81

Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol (2002) 1.80

Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol (2005) 1.79

The two CRYs of the butterfly. Curr Biol (2005) 1.79

Swine as a principal reservoir of hepatitis E virus that infects humans in eastern China. J Infect Dis (2006) 1.78

Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharmacol Exp Ther (2011) 1.77

Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists. Mol Pharmacol (2007) 1.77

Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol (2010) 1.76

Maternal prepregnancy overweight and obesity and the pattern of labor progression in term nulliparous women. Obstet Gynecol (2004) 1.76

Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. J Gastroenterol (2002) 1.76

Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels. Hepatology (2007) 1.75

catena-Poly[[(acetato-κO,O')(methanol-κO)cadmium(II)]-μ-[1,2-bis-(1H-benzimid-azol-2-yl)ethane]-κN:N-[(acetato-κO,O')(methanol-κO)cadmium(II)]-di-μ-chlorido]. Acta Crystallogr Sect E Struct Rep Online (2010) 1.72

Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol (2004) 1.72

Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity. Cancer Res (2010) 1.71

A national estimate of the elective primary cesarean delivery rate. Obstet Gynecol (2005) 1.69

Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology (2010) 1.68

Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol (2006) 1.67

Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int (2010) 1.66

Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A (2004) 1.66

Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α. Gastroenterology (2012) 1.66

Ventral pallidal neurons code incentive motivation: amplification by mesolimbic sensitization and amphetamine. Eur J Neurosci (2005) 1.64